Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04176887Phase 4Unknown
Phase 4, randomised trial of levetiracetam in status epilepticus (SE) (2 arms), sponsored by Tanta University. Primary endpoint: Cessation of convulsion at 30 minutes. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04176887.